4
Changes in Ownership
Aspen Neuroscience, Inc. Filed Acc 0000947871-26-000980
Director bought 1,000,000 shares at $15.00 ($15,000,000)
- Director acquired 2,589,132 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2026-11-02 | Conversion | +196,541 | 196,541 | I | ||
| ORBIMED ADVISORS LLC Director | 2026-11-02 | Conversion | +642,745 | 839,286 | I | ||
| ORBIMED ADVISORS LLC Director | 2026-11-02 | Conversion | +616,984 | 1,456,270 | I | ||
| ORBIMED ADVISORS LLC Director | 2026-11-02 | Conversion | +625,743 | 2,082,013 | I | ||
| ORBIMED ADVISORS LLC Director | 2026-11-02 | Conversion | +507,119 | 2,589,132 | I | ||
| ORBIMED ADVISORS LLC Director | 2026-11-02 | Purchase | +1,000,000 | $15.00 | $15,000,000 | 3,589,132 | I |
| Derivatives | |||||||
| ORBIMED ADVISORS LLC Director | 2026-11-02 | Conversion · Series Seed-2 Convertible Preferred Stock | −196,541 | 0 | I | ||
| ORBIMED ADVISORS LLC Director | 2026-11-02 | Conversion · Series A-1 Convertible Preferred Stock | −642,745 | 0 | I | ||
| ORBIMED ADVISORS LLC Director | 2026-11-02 | Conversion · Series A-2 Convertible Preferred Stock | −616,984 | 0 | I | ||
| ORBIMED ADVISORS LLC Director | 2026-11-02 | Conversion · Series B Convertible Preferred Stock | −625,743 | 0 | I | ||
| ORBIMED ADVISORS LLC Director | 2026-11-02 | Conversion · Series C Convertible Preferred Stock | −507,119 | 0 | I | ||
| Open-market purchases · 1,000,000 sh · avg $15.00 · $15,000,000 | |||||||
Loading xslF345X06/ownership.xml…